Qvar redihaler and Staphylococcal infection - a phase IV clinical study of FDA data

Summary:

Staphylococcal infection is reported as a side effect among people who take Qvar redihaler (beclomethasone dipropionate), especially for people who are female, 60+ old, also take Sodium Chloride, and have Immune system disorder.

The phase IV clinical study analyzes which people have Staphylococcal infection when taking Qvar redihaler. It is created by eHealthMe based on reports of 2,526 people who have side effects when taking Qvar redihaler from the FDA, and is updated regularly.

What is Qvar redihaler?

Qvar redihaler has active ingredients of beclomethasone dipropionate. eHealthMe is studying from 2,531 Qvar redihaler users. Check the latest studies of Qvar redihaler.

What is Staphylococcal infection?

Staphylococcal infection (an infection with staphylococcus bacteria) is found to be associated with 1,724 drugs and 1,898 conditions by eHealthMe. Check the latest studies of Staphylococcal infection.

On Jul, 12, 2026

2,526 people reported to have side effects when taking Qvar redihaler.
Among them, 17 people (0.67%) have Staphylococcal infection.

Could Qvar redihaler cause Staphylococcal infection?

Among these 17 people:

What is the gender of people who have Staphylococcal infection when taking Qvar redihaler? *

female: 76.47 %
male: 23.53 %

What is the age of people who have Staphylococcal infection when taking Qvar redihaler? *

What are other drugs people take besides Qvar redihaler? *

Sodium Chloride: 9 people, 52.94%
Zofran: 8 people, 47.06%
Spiriva: 7 people, 41.18%
Heparin: 7 people, 41.18%
Novolog: 7 people, 41.18%
Epinephrine: 7 people, 41.18%
Diphenhydramine Hydrochloride: 7 people, 41.18%
Depakote: 7 people, 41.18%
Qnasl: 7 people, 41.18%
Qvar: 7 people, 41.18%

What are other side effects people have besides Staphylococcal infection? *

Fall: 12 people, 70.59%
Weakness: 7 people, 41.18%
Fever: 7 people, 41.18%
Cough: 7 people, 41.18%
Facial Bones Fracture (bone fracture of face): 7 people, 41.18%
Hepatic Enzyme Increased: 6 people, 35.29%
Memory Loss: 6 people, 35.29%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 35.29%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 35.29%
Infusion Site Erythema (reddening of the skin at infusion site): 6 people, 35.29%

What are the existing conditions these people have? *

Immune System Disorder: 7 people, 41.18%
Immunodeficiency Common Variable: 6 people, 35.29%
Asthma: 4 people, 23.53%
Cystic Fibrosis (disease of the secretary glands): 2 people, 11.76%
Pain: 1 person, 5.88%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Qvar redihaler and have Staphylococcal infection?

- Check whether Staphylococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qvar redihaler:

Qvar redihaler (2,531 reports)

Browse all side effects of Qvar redihaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staphylococcal infection:

Staphylococcal infection (1,724 drugs)

Browse all the conditions that are associated with Staphylococcal infection:

Staphylococcal infection (1,898 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate (the active ingredients of Qvar redihaler) and Qvar redihaler (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.